The effects on the ovulatory cycle of metoclopramide-induced increased prolactin levels during follicular development.
D004311:Double-Blind Method; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008598:Menstruation; D008787:Metoclopramide / Q000494:pharmacology*; D010060:Ovulation; D010919:Placebos; D011388:Prolactin / Q000097:blood*; D011897:Random Allocation
D010919:Placebos; D011388:Prolactin; D008787:Metoclopramide